This is a $8,122.48 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IBRANCE 100 MG TABLET 7S, with a period of performance ending on June 9, 2025. The award was made on May 16, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,065.75, is for the delivery of IBRANCE 100 MG TABLET 7S, a pharmaceutical product. The contract is a firm fixed-price arrangement with a completion date of December 27, 2024. The award is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,792.08 Firm Fixed Price Delivery Order contract is for the supply of IBRANCE 125 MG TABLET 7S, a specialty pharmaceutical product. The award has an ultimate completion date of December 2, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $7,792.08 firm-fixed-price contract is for the delivery of IBRANCE 125 MG TABLET 7S, a pharmaceutical product. The contract has an ultimate completion date of October 3, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including military treatment facilities and...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IBRANCE 125 MG TABLET 7S, a pharmaceutical product, with a ceiling value of $8,118.08 and a performance period ending on July 14, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a federal delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $7,796.30 firm-fixed-price contract is for the supply of IBRANCE 100 MG TABLET 7S, a prescription drug product, with a period of performance through November 1, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with various federal agencies, including a $999,999,999 IDC with DLA Troop Support Medical...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of IBRANCE 125 MG TABLET 7S. The contract has a firm fixed price of $7,792.08 and a completion date of October 9, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the delivery of a...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract, valued at $7,792.08, is for the supply of IBRANCE 125 MG TABLET 7S, a pharmaceutical product. The delivery order is part of a larger indefinite delivery contract (IDC) awarded to AmerisourceBergen Drug Corp, valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,792.08 firm-fixed-price delivery order is for the supply of IBRANCE 125 MG TABLET 7S, a pharmaceutical product, with a completion date of December 4, 2024. The contract is not designated with any set-aside requirements, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of the pharmaceutical product IBRANCE 125 MG TABLET 7S, with a completion date of March 5, 2024 and a potential value of $7,792.08. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor on this order, which is not designated as a set-aside. The company...